{
    "clinical_study": {
        "@rank": "114404", 
        "arm_group": [
            {
                "arm_group_label": "CVP", 
                "arm_group_type": "Active Comparator", 
                "description": "CVP-guided vasodilator-induced hypovolemia"
            }, 
            {
                "arm_group_label": "SVV", 
                "arm_group_type": "Experimental", 
                "description": "SVV-guided vasodilator-induced hypovolemia"
            }
        ], 
        "brief_summary": {
            "textblock": "Induced hypovolemia is known to improve surgical field during living donor hepatectomy. This\n      procedure is conventionally guided by monitoring the central venous pressure (CVP). Stroke\n      volume variation (SVV) is a novel method to substitute with CVP to monitor cardiac preload.\n      The investigators try to evaluate the relationship between CVP and SVV during CVP-guided\n      vasodilator induced hypovolemia (validation study). Then, feasibility of vasodilator induced\n      hypovolemia using the SVV calculated from the validation study will be tested (feasibility\n      study)."
        }, 
        "brief_title": "Vasodilator-induced Hypovolemia in Living Liver Donors", 
        "condition": [
            "CVP and SVV During Living Donor Hepatectomy", 
            "Surgical Field Grade (Condition of Surgical Field; Bleeding, Tension of the IVC)"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hemorrhage", 
                "Hypovolemia"
            ]
        }, 
        "detailed_description": {
            "textblock": "This is a 2-phases study.\n\n      first phase validation study : Evaluation of the relationship between CVP and SVV during\n      CVP-guided vasodilator induced hypovolemia\n\n      second phase feasibility study\n\n      : Comparison of the surgical field grade between validation study group(CVP guided group)\n      and feasibility study group(SVV guided group)"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  adult (20-60 yr)\n\n          -  elective living liver donors\n\n        Exclusion Criteria:\n\n          -  not obtained informed consent"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "60 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "42", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 8, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02033967", 
            "org_study_id": "MLN_SVV_CVP"
        }, 
        "intervention": {
            "arm_group_label": [
                "CVP", 
                "SVV"
            ], 
            "intervention_name": "vasodilator induced hypovolemia", 
            "intervention_type": "Procedure", 
            "other_name": "Milrinone induced hypovolemia"
        }, 
        "intervention_browse": {
            "mesh_term": "Vasodilator Agents"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "liver donor", 
            "hepatectomy", 
            "vasodilator", 
            "central venous pressure", 
            "stroke volume variation"
        ], 
        "lastchanged_date": "January 13, 2014", 
        "location": {
            "contact": {
                "email": "Jeonghee.cha@gmail.com", 
                "last_name": "Jeonghee Cha"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "110-744"
                }, 
                "name": "Seoul national University Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Vasodilator-induced Hypovolemia in Living Liver Donors: Central Venous Pressure-guided vs Stroke Volume Variation-guided Technique", 
        "overall_contact": {
            "email": "spss@dreamwiz.com", 
            "last_name": "Chul-Woo Jung, MD"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Korea: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Target value of SVV is calculated from the linear regression equation that was calculated from scatter plot made with CVP and SVV values during CVP-guided vasodilator induced hypovolemia (validation study).", 
            "measure": "target value of SVV", 
            "safety_issue": "Yes", 
            "time_frame": "during living donor hepatectomy"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02033967"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Seoul National University Hospital", 
            "investigator_full_name": "Chul-Woo Jung", 
            "investigator_title": "associate professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "<4 point scale> Grade l: Very lax IVC and hepatic veins, minimal bleeding at resection plane, very easy to operate Grade ll: Lax IVC and hepatic veins, a little bleeding at resection plane, easy to operate Grade lll: Tense IVC and hepatic veins, appreciable bleeding at resection plane, somewhat difficult to operate Grade lV: Very tense IVC and hepatic veins, profuse bleeding at resection plane, very difficult to operate", 
                "measure": "surgical field", 
                "safety_issue": "Yes", 
                "time_frame": "during living donor hepatectomy"
            }, 
            {
                "measure": "use of inotropics", 
                "safety_issue": "Yes", 
                "time_frame": "during living donor hepatectomy"
            }, 
            {
                "measure": "estimated blood loss", 
                "safety_issue": "Yes", 
                "time_frame": "during living donor hepatectomy"
            }
        ], 
        "source": "Seoul National University Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Seoul National University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}